ROCHESTER, N.Y., May 7, 2020 /PRNewswire/ -- Vuzix®
Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a
leading supplier of Smart Glasses and Augmented Reality (AR)
technology and products, announces that Pixee Medical, a
France-based medical company, has
received CE marking certification for Knee+, the first orthopedic
navigation system using augmented reality smart glasses for total
knee arthroplasty.
The unique patented technology, combining proprietary computer
vision and deep learning algorithms, uses Vuzix' M400 Smart Glasses
to precisely track instruments and implants during surgeries.
Compared to bulky and expensive robotic solutions, Knee+ is simple
to use, cost effective and does not require preoperative DICOM or
disposables.
The CE marking certification for Knee+ is a major milestone for
Pixee Medical as it allows the commercialization of its innovative
product across the European Union and other CE Mark geographies by
using implant manufacturers as distributors. Pixee Medical was also
granted ISO 13485:2016 certification and is pursuing and expecting
FDA approval (510k) for Knee+ before
the end of 2020.
"Pixee Medical has developed a device which aims to apply AR to
knee and then shoulder surgery, guiding the practitioner through
connected glasses, like a GPS. The solution is simple,
accurate and much less expensive than surgical assistance
robots. We're excited to work directly with Vuzix AR Smart
Glasses to offer this solution to European Union and other CE mark
geographies through implant manufacturers and distributors,"
commented Sébastien Henry, Founding President of Pixee Medical.
"The introduction of the Vuzix M400 Smart Glasses has opened up
a new vertical in the medical space for Vuzix. The team at
Pixee Medical has created an innovative path to bring the Vuzix
M400 Smart Glasses into the operating room to perform knee
replacement surgeries," said Paul Travers, President and Chief
Executive Officer at Vuzix.
Pixee Medical raised over 2.5 million € and won the last French
I-Nov contest with a grant of 1.2 million € in order to support
technological breakthroughs in computer assisted orthopedic
solutions. The next development for Pixee Medical is a
shoulder implant navigation system, which will display a hologram
in the surgeon's glasses to precisely guide him, through the skin,
during an operation.
About Pixee Medical
The Pixee Medical company was founded in 2017 with the goal of
creating high-performance, computer-assisted surgical solutions
using advanced computer vision and artificial intelligence
technologies, while remaining affordable in the challenging health
system environment. Our team is composed of experts in orthopedic
and computer assisted surgery with recent graduates at the
forefront of technology. Our vision is to augment surgeon's
capabilities by creating new clinical pathways that are both
efficient and effective. We aim to market our first surgical
devices in 2020, in Europe and
abroad, in compliance with our ISO 13485 certification, CE marking
and to enter soon the US market with a forthcoming FDA 510(k).
For more information visit our linkedin, Website or email
us at contact@pixee-medical.com
About Vuzix Corporation
Vuzix is a leading supplier of Smart-Glasses and Augmented
Reality (AR) technologies and products for the consumer and
enterprise markets. The Company's products include personal display
and wearable computing devices that offer users a portable
high-quality viewing experience, provide solutions for mobility,
wearable displays and augmented reality. Vuzix holds 157 patents
and patents pending and numerous IP licenses in the Video Eyewear
field. The Company has won Consumer Electronics Show (or CES)
awards for innovation for the years 2005 to 2020 and several
wireless technology innovation awards among others. Founded in
1997, Vuzix is a public company (NASDAQ: VUZI) with offices in
Rochester, NY, Oxford, UK, and Tokyo, Japan. For more information,
visit
Vuzix website, Twitter and Facebook pages.
Forward-Looking Statements Disclaimer
Certain statements contained in this news release are
"forward-looking statements" within the meaning of the Securities
Litigation Reform Act of 1995 and applicable Canadian securities
laws. Forward looking statements contained in this release relate
to the Vuzix Blade Smart Glasses, our relationship with Pixee
Medical, future business opportunities, and among other things the
Company's leadership in the Smart Glasses and AR display industry.
They are generally identified by words such as "believes," "may,"
"expects," "anticipates," "should" and similar expressions. Readers
should not place undue reliance on such forward-looking statements,
which are based upon the Company's beliefs and assumptions as of
the date of this release. The Company's actual results could differ
materially due to risk factors and other items described in more
detail in the "Risk Factors" section of the Company's Annual
Reports and MD&A filed with the United States Securities and
Exchange Commission and applicable Canadian securities regulators
(copies of which may be obtained at www.sedar.com or www.sec.gov).
Subsequent events and developments may cause these forward-looking
statements to change. The Company specifically disclaims any
obligation or intention to update or revise these forward-looking
statements as a result of changed events or circumstances that
occur after the date of this release, except as required by
applicable law.
Media and Investor Relations Contact:
Ed McGregor, Director of Investor
Relations, Vuzix Corporation ed_mcgregor@vuzix.com Tel: (585)
359-5985
Vuzix Corporation, 25 Hendrix Road, Suite A, West Henrietta, NY 14586 USA,
Investor Information – IR@vuzix.com www.vuzix.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/vuzix-announces-the-worlds-first-orthopedic-navigation-system-using-augmented-reality-smart-glasses-developed-by-pixee-medical-301055145.html
SOURCE Vuzix Corporation